RAYSTATION
Report
- Report Number
- 3010034862-2025-00003
- Event Type
- Malfunction
- Date Received
- November 27, 2025
- Date of Event
- November 7, 2025
- Report Date
- November 27, 2025
- Manufacturer
- RAYSEARCH LABORATORIES AB (PUBL)
- Product Code
- MUJ
- Product Problem
- Yes
- Report Source
- Distributor report
- Reporter Location
- NL
- Reporter Occupation
- OTHER
Narratives
IN RAYSTATION, THE USER CAN DEFINE VOLUMES, REGIONS OF INTEREST, ROIS, WHERE THE IMAGE DATA USED FOR DOSE CALCULATION IS OVERRIDDEN WITH A BULK DENSITY ASSIGNMENT. THIS IS CALLED MATERIAL OVERRIDE, MO, AND MAY BE REQUIRED WHEN THE PATIENT HAS IMPLANTS OF MATERIALS THAT ARE NOT WELL REPRESENTED IN THE IMAGE DATA OR WHEN THERE ARE ARTIFACTS IN THE IMAGES. USING MATERIAL OVERRIDE IN SUCH SITUATIONS IMPROVES THE DOSE CALCULATION ACCURACY. IF THE DOSE CALCULATION DOES NOT CORRECTLY TAKE INTO ACCOUNT THE MO ROIS DEFINED, THE ESTIMATED RADIATION DOSE CALCULATED BY RAYSTATION MAY DIFFER FROM THE DELIVERED DOSE. IN RARE CASES, THE CALCULATED RADIATION DOSE IS NOT INVALIDATED AS INTENDED WHEN A GEOMETRY IS ADDED OR CHANGED OR MO IS REMOVED FOR AN ROI THAT HAS A MO DEFINED OR IS OF TYPE BOLUS, FIXATION OR SUPPORT. THIS CAN OCCUR ONLY FOR AN ROI THAT HAS A PRIMARYSHAPE, BUT NO CONTOURS. THIS CAN BE THE CASE, E.G., IF ALL CONTOURS HAVE BEEN DELETED OR IF A DERIVED ROI IS CREATED AND RESULTS IN AN EMPTY GEOMETRY. WHEN CONTOURS ARE ADDED OR CHANGED FOR SUCH AN ROI, DOSE IS NOT INVALIDATED. THE TREATMENT PLAN CAN BE APPROVED AND EXPORTED WITH THE DOSE IN THIS INCONSISTENT STATE.
A USER HAS REPORTED THAT DURING WHEN WORKING ON A TREATMENT PLAN, THEY NOTICED THAT THE CALCULATED RADIATION DOSE WAS NOT INVALIDATED AS EXPECTED WHEN THEY CHANGED THE PROPERTIES OF A REGION OF INTEREST, ROI. THERE WAS NO IMPACT ON THE PATIENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2727967 | RAYSTATION | RADIATION THERAPY TREATMENT PLANNING SYSTEM | MUJ | RAYSEARCH LABORATORIES AB (PUBL) | 10B-V2025 SP1 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown |